登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Can J Anaesth，2月12日，Practical Recommendations for Critical Care and Anesthesiology Teams Caring for Novel Coronavirus (2019-nCoV) Patients》

  • 来源专题：COVID-19科研动态监测
  • 编译者： xuwenwhlib
  • 发布时间：2020-02-18

  • Practical Recommendations for Critical Care and Anesthesiology Teams Caring for Novel Coronavirus (2019-nCoV) Patients

    Randy S Wax , Michael D Christian

    PMID: 32052373 DOI: 10.1007/s12630-020-01591-x

    Abstract

    A global health emergency has been declared by the World Health Organization as the 2019-nCoV outbreak spreads across the world, with confirmed patients in Canada. Patients infected with 2019-nCoV are at risk for developing respiratory failure and requiring admission to critical care units. While providing optimal treatment for these patients, careful execution of infection control measures is necessary to prevent nosocomial transmission to other patients and to healthcare workers providing care. Although the exact mechanisms of transmission are currently unclear, human-to-human transmission can occur, and the risk of airborne spread during aerosol-generating medical procedures remains a concern in specific circumstances. This paper summarizes important considerations regarding patient screening, environmental controls, personal protective equipment, resuscitation measures (including intubation), and critical care unit operations planning as we prepare for the possibility of new imported cases or local outbreaks of 2019-nCoV. Although understanding of the 2019-nCoV virus is evolving, lessons learned from prior infectious disease challenges such as Severe Acute Respiratory Syndrome will hopefully improve our state of readiness regardless of the number of cases we eventually manage in Canada.

  • 原文来源：https://pubmed.ncbi.nlm.nih.gov/32052373-practical-recommendations-for-critical-care-and-anesthesiology-teams-caring-for-novel-coronavirus-2019-ncov-patients/?from_term=COVID-19&from_sort=date&from_sort_order=asc&from_pos=3
80浏览量
原文链接
相关报告

  • 《CDC，2月14日，Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-02-14
    • Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020 Weekly / February 14, 2020 / 69(6);166–170 On February 7, 2020, this report was posted online as an MMWR Early Release. Kristina L. Bajema, MD1,2; Alexandra M. Oster, MD3; Olivia L. McGovern, PhD1,2; Stephen Lindstrom, PhD4; Mark R. Stenger, MA5; Tara C. Anderson, DVM, PhD6; Cheryl Isenhour,, DVM2; Kevin R. Clarke, MD7; Mary E. Evans, MD8; Victoria T. Chu, MD1,4; Holly M. Biggs, MD4; Hannah L. Kirking, MD4; Susan I. Gerber, MD4; Aron J. Hall, DVM4; Alicia M. Fry, MD9; Sara E. Oliver, MD2; 2019-nCoV Persons Under Investigation In December 2019, a cluster of cases of pneumonia emerged in Wuhan City in central China’s Hubei Province. Genetic sequencing of isolates obtained from patients with pneumonia identified a novel coronavirus (2019-nCoV) as the etiology (1). As of February 4, 2020, approximately 20,000 confirmed cases had been identified in China and an additional 159 confirmed cases in 23 other countries, including 11 in the United States (2,3). On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S. airports to identify ill travelers returning from Wuhan City (4). CDC activated its Emergency Operations Center on January 21 and formalized a process for inquiries regarding persons suspected of having 2019-nCoV infection (2). As of January 31, 2020, CDC had responded to clinical inquiries from public health officials and health care providers to assist in evaluating approximately 650 persons thought to be at risk for 2019-nCoV infection. Guided by CDC criteria for the evaluation of persons under investigation (PUIs) (5), 210 symptomatic persons were tested for 2019-nCoV; among these persons, 148 (70%) had travel-related risk only, 42 (20%) had close contact with an ill laboratory-confirmed 2019-nCoV patient or PUI, and 18 (9%) had both travel- and contact-related risks. Eleven of these persons had laboratory-confirmed 2019-nCoV infection. Recognizing persons at risk for 2019-nCoV is critical to identifying cases and preventing further transmission. Health care providers should remain vigilant and adhere to recommended infection prevention and control practices when evaluating patients for possible 2019-nCoV infection (6). Providers should consult with their local and state health departments when assessing not only ill travelers from 2019-nCoV-affected countries but also ill persons who have been in close contact with patients with laboratory-confirmed 2019-nCoV infection in the United States.
    161浏览量
    原文链接

  • 《MedRxiv，2月23日，Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-02-24
    • Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China Mingli Yuan, Wen Yin, Zhaowu Tao, Weijun Tan, Yi Hu doi: https://doi.org/10.1101/2020.02.22.20024927 Abstract Radiologic characteristics of 2019 novel coronavirus (2019-nCoV) infected pneumonia (NCIP) which had not been fully understood are especially important for diagnosing and predicting prognosis. We retrospective studied 27 consecutive patients who were confirmed NCIP, the clinical characteristics and CT image findings were collected, and the association of radiologic findings with mortality of patients was evaluated. 27 patients included 12 men and 15 women, with median age of 60 years (IQR 47-69). 17 patients discharged in recovered condition and 10 patients died in hospital. The median age of mortality group was higher compared to survival group (68 (IQR 63-73) vs 55 (IQR 35-60), P = 0.003). The comorbidity rate in mortality group was significantly higher than in survival group (80% vs 29%, P = 0.018). The predominant CT characteristics consisted of ground glass opacity (67%), bilateral sides involved (86%), both peripheral and central distribution (74%), and lower zone involvement (96%). The median CT score of mortality group was higher compared to survival group (30 (IQR 7-13) vs 12 (IQR 11-43), P = 0.021), with more frequency of consolidation (40% vs 6%, P = 0.047) and air bronchogram (60% vs 12%, P = 0.025). An optimal cutoff value of a CT score of 24.5 had a sensitivity of 85.6% and a specificity of 84.5% for the prediction of mortality. 2019-nCoV was more likely to infect elderly people with chronic comorbidities. CT findings of NCIP were featured by predominant ground glass opacities mixed with consolidations, mainly peripheral or combined peripheral and central distributions, bilateral and lower lung zones being mostly involved. A simple CT scoring method was capable to predict mortality. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    146浏览量
    原文链接